Coya Therapeutics Announces Issuance Of New U.S. Patent Protecting Methods Of Producing Recombinant Human (Rh) Interleukin-2 (Aldesleukin) Liquid Formulations
June 2 (Reuters) - Coya Therapeutics Inc COYA.O:
COYA THERAPEUTICS ANNOUNCES ISSUANCE OF NEW U.S. PATENT PROTECTING METHODS OF PRODUCING RECOMBINANT HUMAN (RH) INTERLEUKIN-2 (ALDESLEUKIN) LIQUID FORMULATIONS
COYA THERAPEUTICS INC - TO SUBMIT IND FOR COYA 302 BY END OF JUNE
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.